ER+, HER 2- breast cancer

Clinical trials for ER+, HER 2- breast cancer explained in plain language.

Never miss a new study

Get alerted when new ER+, HER 2- breast cancer trials appear

Sign up with your email to follow new studies for ER+, HER 2- breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug IDE574 enters human trials for Hard-to-Treat cancers

Disease control Recruiting now

This study tests a new drug called IDE574 in people with advanced solid tumors or a specific type of breast cancer (ER+, HER2-). The drug targets two enzymes that help cancer cells grow. The study has two parts: first, testing IDE574 alone in various cancers; second, combining it…

Matched conditions: ER+, HER 2- BREAST CANCER

Phase 1 • Sponsor: IDEAYA Biosciences • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

ER+, HER 2- breast cancer

Get alerted when new ER+, HER 2- breast cancer trials appear

New drug IDE574 enters human trials for Hard-to-Treat cancers